• Reuters


U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin care firm Ci:z Holdings Co. that it does not already own for ¥230 billion ($2.05 billion) in cash.

J&J is betting the deal — which will give it ownership of popular brands such as Dr.Ci:Labo, Labo Labo and Genomer — will help it strengthen its international innovation pipeline.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.